International Ataxia Awareness Day (IAAD) is on September 25 of each year. It is a coordinated effort from individuals and

Current Stage of DevelopmentAn open label, phase 2 trial, with the primary objective of testing the safety and tolerability of

On November 29, 2022, the California Institute for Regenerative Medicine (CIRM) awarded Dr Stephanie Cherqui and colleagues at the University

The human experience is such a beautifully complicated journey. We all learn, grow, develop opinions, follow tendencies, change, adapt, and

The effects of Friedreich’s ataxia (FA) are vicious, relentless, widespread, and undeniable. FA uses my own body to slowly defeat

Battling a degenerative disease, especially one so rare that most people haven’t heard of it, can be a lonely journey.

Opportunities to communicate with the patient community over time, while maintaining patient confidentialityEnhanced patient recruitment through targeted recruitment notices to

The protein associated with F A, called frataxin, is made by the FXN gene and is required for proper functioning

The aim of this study was to determine the prevalence and relative importance of symptoms experienced by children and adults

Patient registry information is never used for fundraising.Patient registry information is not shared with researchers and pharmaceutical companies without appropriate